Uniseed has appointed Alastair Hick as its next Chief Executive Officer, marking a new chapter in the fund’s 25-year history. He will formally take the helm in January 2026, succeeding Peter Devine, who will leave the organisation in December after 20 years in the role.
Uniseed names Alastair Hick as new CEO to lead next phase of growth
October 29, 2025 Australian BiotechBioPharmaDispatch Executive
Latest Video
New Stories
-
Australian medtech secures funds to advance real-time breast cancer surgery technology
February 13, 2026 - - Australian Biotech -
The Dispatched Podcast 'Week in Review' - 13 February
February 13, 2026 - - Podcast -
PBAC to reconsider broader vaccine funding after late addition to March agenda
February 13, 2026 - - Latest News -
Ten years of process 'improvements' is almost the point, says Anne Ruston
February 13, 2026 - - Latest News -
Senate scrutiny of PBS rules after Canberra family highlights lack of biologic access
February 12, 2026 - - Latest News -
There is no negotiation, yet, so be careful not to give the impression of conceding anything
February 11, 2026 - - Latest News -
Arrotex and Pfizer forge strategic pharmacy partnership for ENBREL in Australia
February 11, 2026 - - Latest News

